PHARMACEUTICAL PREPARATIONS UTILIZED

Brand Owner (click to sort) Address Description
FLUXID SRZ Properties, Inc. c/o Schwarz Pharma, Inc. 6140 West Executive Drive Mequon WI 53092 PHARMACEUTICAL PREPARATIONS UTILIZED FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INCLUDING HEARTBURN AND ACID REFLUX;
RAPCID SRZ Properties, Inc. c/o Schwarz Pharma, Inc. 6140 West Executive Drive Mequon WI 53092 PHARMACEUTICAL PREPARATIONS UTILIZED FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INCLUDING HEARTBURN AND ACID REFLUX;
REFLUXIN SRZ Properties, Inc. c/o Schwarz Pharma, Inc. 6140 West Executive Drive Mequon WI 53092 PHARMACEUTICAL PREPARATIONS UTILIZED FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INCLUDING HEARTBURN AND ACID REFLUX;REFLUX IN;
ZYFLUX SRZ Properties, Inc. c/o Schwarz Pharma, Inc. 6140 West Executive Drive Mequon WI 53092 PHARMACEUTICAL PREPARATIONS UTILIZED FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INCLUDING HEARTBURN AND ACID REFLUX;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for treating secretory diarrhea. The compositions and pharmaceutical preparations of the invention may comprise one or more thiazolidinone compounds, and may additionally comprise one or more pharmaceutically acceptable carriers, excipients, and/or diluents.